Addus HomeCare Corporation
NASDAQ:ADUSMedical - Care Facilities
+$0.29 today
- Market cap
- $2.25B
- Beta
- 0.90
- P/E (TTM)
- 17.4
- EPS (TTM)
- $5.40
Volume 0.23M
Average 0.25M
ADUS Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Addus HomeCare CorporationNASDAQ: ADUS
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables declines year over year
Q2 FY2026 accounts receivables of $5.83M (cash outflow) fell 9.9% year over year, ahead of the -1289.6% change in trailing-twelve-month accounts receivables.
Context
- Accounts receivables amounted to 1.9% of revenue in FY2025, unchanged from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -9.9% holds above the trailing-twelve-month pace of -1289.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (26.65M) USD
- Year-over-year change
- -220.4%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (26.65M) | -220.4% |
| FY2024 | 2024-12-31 | 22.14M | +41.3% |
| FY2023 | 2023-12-31 | 15.67M | -23.9% |
| FY2022 | 2022-12-31 | 20.59M | +625.8% |
| FY2021 | 2021-12-31 | (3.92M) | — |
Accounts Receivables vs competitors
How ADUS compares with its peers on the latest reported figures
- ADUS's LTM Jun 2026 accounts receivables of $9.98M is the 5th largest of the 7 companies compared; the peer median is $7.57M.
- Its year-over-year change of -1289.6% is the lowest of 7, against a peer median of +270.9%.
- Accounts receivables amounts to 0.7% of revenue for ADUS, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $91.03M | +197.4% | -5.1% | 1.7% | |
| LTM Jun 2026 | $62.9M | +362.5% | -3.5% | 1.0% | |
| LTM Oct 2026 | $16.53M | +166.8% | +110.8% | 0.6% | |
| LTM Mar 2026 | $10.3M | -57.9% | +305.9% | 1.0% | |
| LTM Jun 2026 | $9.98M | -1289.6% | — | 0.7% | |
| LTM Sep 2026 | $8.96M | +344.5% | -1.6% | 0.6% | |
| LTM Jun 2026 | $4.85M | +1224.0% | +68.7% | 0.2% | |
| Peer median (excluding ADUS) | $7.57M | +270.9% | +33.6% | 0.8% | |
Competitors are the stored peer set for ADUS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 45.13M | 46.03M | 62.52M | 73.6M | 95.91M |
| Depreciation & Amortization | 14.49M | 14.06M | 14.13M | 13.53M | 16.41M |
| Deferred Income Tax | 7.28M | 3.91M | 2.82M | 13.19M | 17.87M |
| Stock-Based Compensation | 9.43M | 10.63M | 10.32M | 11.17M | 16.42M |
| Change in Working Capital | (38.61M) | 27.78M | 20.89M | 1.51M | (37.98M) |
| Accounts Receivables | (3.92M) | 20.59M | 15.67M | 22.14M | (26.65M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (4.81M) | 2.51M | 2.03M | (1.91M) | (12.66M) |
| Other Working Capital | (29.89M) | 4.67M | 3.2M | (18.72M) | 1.32M |
| Other Non-Cash Items | 1.77M | 2.71M | 1.58M | 3.44M | 2.88M |
| Operating Cash Flow | 39.49M | 105.11M | 112.25M | 116.43M | 111.51M |
| Capital Expenditures | (4.65M) | (8.3M) | (9.45M) | (6.05M) | (7.72M) |
| Acquisitions (Net) | (37.37M) | (98.29M) | (109.8M) | (348.59M) | (24.8M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 15K | 29K | 15K |
| Investing Cash Flow | (42.02M) | (106.59M) | (119.24M) | (354.61M) | (32.5M) |
| Debt Repayment | 28.27M | (90M) | (8.5M) | 96.65M | (98.67M) |
| Common Stock Issued | 1.11M | 2.55M | 319K | 179.04M | 2.48M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.03M) | 0 | 0 | (3.39M) | (113K) |
| Financing Cash Flow | 26.34M | (87.45M) | (8.18M) | 272.3M | (96.3M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 23.82M | (88.93M) | (15.17M) | 34.12M | (17.29M) |
| Free Cash Flow | 34.84M | 96.81M | 102.79M | 110.38M | 103.79M |
Addus HomeCare Corporation
NASDAQ:ADUS
Intrinsic Alpha fair value
Locked
Current Price
$120.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.